Sonoma Pharmaceuticals

Sonoma Pharmaceuticals develops and produces stabilized hypochlorous acid (HOCl) products for a variety of applications, including wound care, dermatology, animal health care, eye care, and oral care. The company offers a range of products, such as Epicyn, an antimicrobial facial cleanser; Levicyn, which alleviates symptoms associated with dermatoses; and Celacyn gel, designed to promote healing of scars from surgical procedures and trauma. Additional offerings include SebuDerm for managing seborrheic dermatitis, Ceramax for dry and irritated skin, and Acuicyn for eye area hygiene. Microcyn, along with its variants, targets expedited healing for various wounds and skin conditions, addressing both common and antibiotic-resistant pathogens. Sonoma Pharmaceuticals operates globally, marketing over 100 products in 33 countries, focusing on unmet medical needs in advanced wound management, dermatology, and animal health. The company, previously known as Oculus Innovative Sciences, was incorporated in 1999 and is headquartered in Woodstock, Georgia.